Introduction: Challenges in Current Approaches
to T2DM Management Eleuterio Ferrannini, MD
Professor of Medicine
Pisa University Medical School, IT
11.45 - 12.15
Comparative Evaluation of GLP-1 Analogues
and DPP-4 Inhibitors Bo Ahrén, MD, PhD
Professor of Clinical Metabolism
Lund University, SE
12.15 - 12.45
New GLP-1 Science: Investigating Extrapancreatic Effects Jens Juul Holst, MD
Professor of Medical Physiology
Panum Institute, University of Copenhagen, DK
12.45 - 13.15
Evolving Data on Incretin-based Therapies:
A Closer Look at GLP-1 Analogues Ralph A. DeFronzo, MD
Professor of Medicine
University of Texas Health Science Center, USA
13.15 - 13.30
Q&A Session
13.30 - 14.30
Lunch
For further information please contact:
Website: www.viennaincretins09.com